Jun 01, 2023 5:30pm EDT

Medexus to Participate in the LD Micro Invitational XIII

May 10, 2023 5:30pm EDT

Medexus Announces Normal Course Issuer Bid, or NCIB, for Its Convertible Debentures

May 09, 2023 6:21pm EDT

Medexus Demonstrates Cost-Effectiveness of Gleolan-Guided Surgery for High-Grade Glioma

Apr 18, 2023 5:30pm EDT

Medexus to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference

Apr 11, 2023 7:25am EDT

Medexus Expects Record Revenue for Fiscal Year 2023 and Provides Business Update

Mar 22, 2023 7:20am EDT

Medexus Announces New License Deal for Topical Terbinafine

Mar 08, 2023 5:00pm EST

Medexus Announces US$58.5 million in New Credit Facilities

Mar 06, 2023 8:00am EST

Medexus to Participate in 35th Annual Roth Conference

Feb 08, 2023 5:00pm EST

Medexus Announces Another Record Quarter with Fiscal Q3 2023 Revenue of US$28.7 Million, a 35% Increase Over Fiscal Q3 2022

Feb 06, 2023 5:00pm EST

Medexus Welcomes Two New Board Members